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Abstract
Background: Infection with Streptococcus pneumoniae is a major cause of childhood morbidity and mortality worldwide,
especially in low income countries where pneumococcal conjugate vaccines (PCVs) are still underused. In countries where
PCVs have been introduced, much of their efficacy has resulted from their impact on nasopharyngeal carriage in vaccinated
children. Understanding the epidemiology of carriage for S. pneumoniae and other common respiratory bacteria in
developing countries is crucial for implementing appropriate vaccination strategies and evaluating their impact.
Methods and Findings: We have systematically reviewed published studies reporting nasopharyngeal or oropharyngeal
carriage of S. pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and Neisseria meningitidis in
children and adults in low and lower-middle income countries. Studies reporting pneumococcal carriage for healthy
children ,5 years of age were selected for a meta-analysis. The prevalences of carriage for S. pneumoniae, H. influenzae, and
M. catarrhalis were generally higher in low income than in lower-middle income countries and were higher in young
children than in adults. The prevalence of S. aureus was high in neonates. Meta-analysis of data from young children before
the introduction of PCVs showed a pooled prevalence estimate of 64.8% (95% confidence interval, 49.8%–76.1%) in low
income countries and 47.8% (95% confidence interval, 44.7%–50.8%) in lower-middle income countries. The most frequent
serotypes were 6A, 6B, 19A, 19F, and 23F.
Conclusions: In low and lower-middle income countries, pneumococcal carriage is frequent, especially in children, and the
spectrum of serotypes is wide. However, because data are limited, additional studies are needed to adequately assess the
impact of PCV introduction on carriage of respiratory bacteria in these countries.
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Introduction
Streptococcus pneumoniae (the pneumococcus) is a major cause
of invasive diseases and respiratory tract infections and caused
approximately 500,000 deaths in children,5 years of age in 2008,
mostly in low income countries [1,2]. Asymptomatic nasopharyn-
geal carriage, which plays an essential role in the transmission of S.
pneumoniae, usually precedes invasive pneumococcal disease (IPD)
[3].
Since 2000, the introduction of the 7-valent pneumococcal
conjugate vaccine (PCV-7,) and second generation PCVs has
significantly reduced the burden of IPD in vaccinated children [4–
11]. PCVs have also reduced IPD in unvaccinated children and
adults [5,8,10,12]. The indirect (or herd) effects of PCVs against
IPD are driven primarily by their impact on carriage of vaccine-
type (VT) pneumococci in vaccinated children, preventing
transmission to unvaccinated contacts [13–15].
Reduction in carriage of VT pneumococci due to PCV
vaccination is often accompanied by an increase in the carriage
of non-vaccine-type (NVT) pneumococci and, to a lesser extent, an
increase in the incidence of IPD caused by NVT pneumococci
[7,8,14,16,17]. However, the overall benefit of PCV-7 vaccination
has not been substantially affected by replacement disease
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[7,8,18,19] except in Alaska and possibly the United Kingdom
[5,20].
By reducing nasopharyngeal carriage of VT pneumococci,
PCVs may also create ecological niches for colonization of
alternative respiratory pathogens such as Staphylococcus aureus,
Haemophilus influenzae, and Moraxella catarrhalis [21], bacteria
that are frequently carried by children and are important causes of
disease worldwide [22–24]. Introducing PCVs may also have
modified carriage of Neisseria meningitidis in children, although
the prevalence of meningococcal carriage is usually higher in
adolescents and young adults [25]. Vaccination with PCV-7 has
been associated with a shift in the etiology of acute otitis media
(AOM) so that non-typeableH. influenzae has become the leading
cause of AOM in place of S. pneumoniae in several studies [26,27].
In addition, some studies have shown that carriage of S.
pneumoniae is inversely related to carriage of S. aureus in healthy
children [21,28,29]. Clarifying the interactions between these
different pathogens is essential to assess overall impact on
conjugate vaccines.H. influenzae type b (Hib) and N. meningitidis
conjugate vaccines are also available and being introduced in low
income countries, which may further influence global patterns of
bacterial carriage [30].
Because the burden of IPD is high in young children in
developing countries, second generation PCVs including more
pneumococcal serotypes are being rapidly introduced into the
Expanded Programme on Immunization of low and lower-middle
income countries [2,31]. Given the impact of PCV-7 childhood
vaccination on carriage and the subsequent indirect benefits seen
in industrialized countries, understanding the dynamics of
pharyngeal carriage of pneumococci in developing countries is
crucial to predict the potential public health implications of
routine PCV use in these settings. Therefore, we have conducted a
systematic literature review to evaluate nasopharyngeal and
oropharyngeal carriage prevalence of S. pneumoniae in children
and adults from low and lower-middle income countries, with a
focus on children ,5 years of age. We have also analyzed the
prevalence of carriage of other common pathogenic respiratory
bacteria that could be affected by the introduction of PCVs.
Methods
Search strategy and selection criteria
We systematically reviewed the literature on the carriage of S.
pneumoniae, H. influenzae, M. catarrhalis, S. aureus, and N.
meningitidis in low and lower-middle income countries, as defined
by the World Bank (Text S1) [32]. We searched PubMed for
articles published in English between January 1, 1990 and
October 23, 2012 using a combination of search strings for
microbiological agents, colonization and carriage, and low income
and lower-middle income countries (Text S1). Websites of the
World Health Organization (www.who.int), the United Nations
International Children’s Emergency Fund (www.unicef.org), and
Google (www.google.com) were searched for additional data. The
review is reported according to the PRISMA statement (Table S2)
[33].
Two reviewers independently screened the titles and abstracts of
all retrieved articles. Disagreements between the two reviewers
were resolved by discussion. Articles that did not contain relevant
information were excluded. In a second step, the full text of the
selected articles was assessed for eligibility using pre-defined
inclusion and exclusion criteria (Protocol S1).
All articles relevant to the objectives of the review and that
reported prevalences of nasopharyngeal or oropharyngeal carriage
of S. pneumoniae, H. influenzae, M. catarrhalis, S. aureus, or N.
meningitidis in children or adults of all ages were included. Articles
were excluded if they were letters (except those reporting results
from studies that had a reasonable sample size and interpretable
results), editorials, comments, or diagnostic articles; lacked
methodology (e.g. no inclusion or exclusion criteria, setting not
clearly described, or were biased); the location from which the
swab was collected, the culture plate, or the method for identifying
pathogens was unclear; reported phase II trials; reported
randomized controlled trials with no usable intervention or
placebo group (if only the placebo group was usable, the article
was included but only the results of the placebo arm were
considered); reported studies with a sample size ,50 (except for
articles on M. catarrhalis); were reviews that included only articles
already covered by the current search.
Assessment of study quality
Reviewers assessed the quality of the studies reviewed by
adapting the criteria of the Coordination of Cancer Clinical
Practice Guidelines [34] for epidemiological studies. Specifically,
the quality of the following were scored as - -, -, 0, +, or ++: study
population clearly described and representative of the source
population; outcome measures described; results applicable to the
subject group targeted in the review; study design and setting
described; main potential confounders identified and taken into
account in the design and analysis; confidence intervals provided;
type of sample collected and the typing method described clearly.
This checklist was not designed to calculate a global quality score
for each study. In case of doubt whether the quality of a study was
sufficient for inclusion, the reviewer discussed the article with a
second reviewer.
Data extraction and analysis
An EndNote (Thomson Reuters, New York, NY) database
containing all the included and excluded articles was created.
Extracted data included country, setting, study years, study design,
population studied, type of swab obtained, culture and identifica-
tion methods, number of subjects, number of swabs, definition of
prevalence, and prevalence of carriage.
Prevalence of carriage (with 95% confidence interval [CI] if
available) was reported for each pathogen for healthy, immuno-
compromised, and ill populations. Ill populations were defined as
subjects with IPD, AOM, sinusitis, or respiratory tract infection
(RTI). When subjects were swabbed once, point prevalence was
defined as the number of positives per total samples or subjects.
When subjects were swabbed several times, average prevalence
was defined as the total number of positive samples divided by the
total number of samples collected, without taking into account the
number of samples taken per subject or the duration of the study.
Period prevalence was defined as the percentage of subjects who
were positive at some point during the study period. The serotype
distribution (expressed as percentage of subjects or isolates) and the
bacterial density (expressed as arbitrary units [35] or bacterial load
calculated as genome equivalent/mL sample secretion [36]) were
also analyzed when data were available.
Meta-analysis
Studies with a similar study design that reported S. pneumoniae
carriage for healthy children ,5 years of age were selected for a
meta-analysis. Studies were included in the meta-analysis if the
articles reported point prevalence estimates (with available number
of subjects positive for carriage and sample size in the target age
group) and if they included at least 100 subjects. Pooled prevalence
estimates of carriage were computed when possible using the
random-effects model of DerSimonian-Laird [37]. Heterogeneity
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between studies was assessed using the I2 statistic. Stata version 11
(StataCorp, College Station, TX) and Metalight (Metalight
Systems, Round Rock, TX) were used for all analyses.
Results
Results of the literature search
We identified 485 articles related to carriage of potentially
pathogenic bacteria from PubMed; 93 were retrieved for
assessment of the full text (Figure 1). Sixty of these articles were
included in the systematic review, 33 of which were from low
income countries and 27 from lower-middle income countries.
These studies were most frequently performed in Africa (N= 38)
and Asia (N= 21). One article was from Oceania. A total of 44
articles reported carriage results for S. pneumoniae, 12 for H.
influenzae, three for M. catarrhalis, four for S. aureus, and nine
for N. meningitidis. Eight articles reported prevalence of carriage
for more than one pathogen.
Carriage of Streptococcus pneumoniae
Thirty-two of the 44 studies that reported prevalence of S.
pneumoniae carriage were conducted in healthy populations, eight
in immunocompromised populations, and six in populations with
IPD, AOM, sinusitis, or RTI (Table 1, Table S2). Three articles
reported prevalence of carriage in both healthy and ill populations
[36,38,39].
One study included oropharyngeal rather than nasopharyngeal
samples [40] and four studies used polymerase chain reaction
(PCR) rather than conventional microbiology to detect carriage
[36,41–43]. Fourteen studies mentioned that sampling, storage,
and culture procedures followed the WHO guidelines for detecting
carriage of S. pneumoniae [44,45]. Calcium alginate was the most
frequent type of swab used (17/44 studies; 38.6%). Four articles
did not report overall prevalence of pneumococcal carriage and
are therefore not listed in Table 1, although they were included in
the review for other outcomes. Three of these articles reported
prevalence of pneumococcal carriage only by serotype [46–48],
and one reported an overall carriage rate that had been published
previously but reported a secondary analysis of bacterial density
and impact of vaccination [35]. All the studies were performed
before the introduction of PCV into the national childhood
immunization program.
The prevalences of S. pneumoniae carriage in healthy children
,5 years of age ranged from 20% to 93.4% in low income
countries and were generally higher than reported in lower-middle
income countries (range, 6.5%–69.8%). Two longitudinal studies
undertaken in The Gambia and Bangladesh reported that all
children carried S. pneumoniae at least once during their first year
of life [49,50]. In The Gambia, carriage rates increased from 20%
within a week of birth to 80%–90% between 3 and 11 months of
age [50]. A similar result was found using PCR [43]. The median
age at first acquisition of S. pneumoniae was 24 days (95% CI, 21–
28) in The Gambia and 38.5 days in Kenya [50,51]. In Kenya, the
acquisition rate of pneumococcal carriage was 0.0189 acquisi-
tions/day (95% CI, 0.0177–0.0202 acquisitions/day) in newborns
and 0.061 acquisitions/day (95% CI, 0.055–0.067) in children ,5
years of age [51,52]. In all the studies that included both children
and adults, the prevalence of carriage was higher in children than
in adults, with the highest rates found in children ,5 years of age
[49,53–56]. The highest prevalence of carriage was in The
Gambia [39,42,43,50,53,54,57]. No major difference in preva-
lence was seen between rural or urban settings in lower-middle
income countries, but data were not available for urban areas in
the low income countries.
All but one study that reported the prevalence of pneumococcal
carriage in immunocompromised populations were conducted in
Human Immunodeficiency Virus (HIV)-infected populations. S.
pneumoniae carriage prevalence in HIV-infected subjects de-
creased with age (76%–88% in children ,5 years of age vs.
11.4%–18% in adults). In Kenya, the prevalence of carriage in
HIV-infected children 3–59 months of age was higher than in
those uninfected (76% [95% CI, 66%–84%] vs. 65.8% [95% CI,
64.0%–67.5%], p = 0.04) [52,58]. One study, from a low income
country (Uganda), reported a 33% prevalence in children aged 8
months–6 years with homozygote sickle cell disease, a prevalence
which was lower than in HIV-infected children in the same age
category [59].
Six studies reported prevalence of S. pneumoniae carriage in ill
subjects, all in children ,5 years of age. Prevalence rates ranged
from 80.2% to 90.1% in low income countries and from 27.9% to
64.4% in lower-middle income countries [36,38,39,60–62]. The
prevalence of carriage was generally lower in children with
radiologically confirmed pneumonia (RCP, 38.7%) than in
children with IPD (90.1%) or RTIs (43.3%–80.2%).
Serotype distribution. Overall serotype distributions were
reported for 33 studies, 22 of which reported details of the
particular serotypes or serogroups detected (Table S3). Overall, a
wide spectrum of serotypes was detected, with up to 74 different
serotypes isolated in one study [57]. Serotypes 6A, 6B, 19A, 19F,
and 23F were the serotypes most commonly isolated. Serotypes 14
and 11A were also frequently isolated. A longitudinal study in The
Gambia showed that serotypes 6B, 19F, 23F, and 6A were the
most commonly isolated pneumococci at first acquisition, whereas
serotypes 6B, 19F, 14, and 6A were the most common isolated in
subsequent episodes of carriage [50]. In addition, NVT were
acquired faster (median age at acquisition, 152 days vs. 174;
p = 0.004) and had a shorter duration of carriage (median
duration, 43 vs. 70 days; p,0.001) than PCV7-serotypes [50].
Between 36% and 56% of the pneumococcal isolates detected in
unvaccinated healthy children ,5 years of age in Africa were of
PCV-7 serotypes [50,51,57,63,64], whereas the proportions were
37%–56% for PHiD-CV (10-valent pneumococcal Haemophilus
influenzae protein D conjugate vaccine) and 50%–64% for PCV-
13 (13-valent pneumococcal conjugate vaccine) [51,63]. Non-
typeable S. pneumoniae represented between 0.7% [55] and
20.6% [60] of the isolates. The highest percentage of non-typeable
S. pneumoniae was in Filipino children with acute lower
respiratory tract infection [60].
Meta-analysis of pneumococcal carriage. The pooled
prevalence for carriage of S. pneumoniae in healthy children ,5
years of age was 64.8% (95% CI, 49.8%–76.1%) for the five
populations from low income countries [52,53,55,63,65] and
47.8% (95% CI, 44.7%–50.8%) for the six populations from
lower-middle income countries (Figure 2) [36,56,66–69]. Howev-
er, studies were highly heterogeneous in the low income countries
(I2 = 98%), in contrast to those in the lower-middle income
countries (I2 = 0%).
Carriage of Haemophilus influenzae
The highest prevalence of H. influenzae carriage detected in a
healthy population (70%) was recorded in a longitudinal study in
infants in a rural setting in The Gambia (Table 2, Table S4) [43].
The study, which used PCR to detect respiratory pathogens,
reported that carriage of H. influenzae was infrequent at birth (,
20% within the first week of life) and increased steadily with age
(.90% at 19 weeks), with a pattern similar to that of S.
pneumoniae [43]. Another study in a post-Hib vaccination setting
reported that H. influenzae carriage rates were lower in children
Respiratory Bacteria Carriage in Low and Lower-Middle Income Countries
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Figure 1. Flowchart of study selection. CoCanCPG, Coordination of Cancer Clinical Practice Guidelines.
doi:10.1371/journal.pone.0103293.g001
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aged $10 years and adults (1.1%–3.9%) than in children ,10
years (21.0%–29.0%) [55]. The prevalence of H. influenzae
carriage in HIV-infected children was reported for India (24%)
[70] and Zambia (29%) [71], two lower-middle income countries.
The prevalence of H. influenzae carriage in ill children from three
lower-middle income countries ranged between 15.2% and 53.5%
[36,61,62]. PCR generally yielded higher rates of H. influenzae
carriage than microbiology in both healthy (31.4%–70% vs.
1.1%–28.6%) and ill (50%–53.5% vs. 15.2%–36.6%) subjects.
Nine studies reported distributions for individual H. influenzae
serotypes, including one conducted after introduction of the Hib
vaccine [55]. Three focused on carriage of Hib [72–74]. The
prevalence of Hib carriage was approximately 5% in these studies,
with the highest prevalence (10.9%) in rural children [72–74]. The
percentage of H. influenzae isolates that belonged to serotype b
was 0.7%–69% in healthy children [43,55,73–76], 0.9%–18% in
sick children [61,62,77], and 49% in immunocompromised
children [70]. Non-typeableH. influenzae were isolated frequently
in studies in which serotyping of H. influenzae was undertaken
Figure 2. Meta-analysis of S. pneumoniae carriage in healthy children under 5 years of age. (A) Low income countries. (B) Lower-middle
income countries. The point prevalence estimate for each study is represented by a square. The 95% confidence interval (CI) for each study is
represented by a horizontal line crossing the square. The size of the square corresponds to the weight of the study in the meta-analysis. All data were
obtained before the introduction of the 7-valent pneumococcal conjugate vaccine.
doi:10.1371/journal.pone.0103293.g002
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(31%–96.4% of all isolates) [55,62,76], except for one study in
Nepalese children that reported a prevalence of non-typeable H.
influenzae of only 1.5% based on oropharyngeal swabs [74].
Carriage of Moraxella catarrhalis
Only three studies reported prevalence of M. catarrhalis
carriage (Table 3, Table S5) [36,43,78]. The highest carriage rate
(71%) in healthy subjects was found in a longitudinal study in
infants in The Gambia [43] which used PCR. In a study of M.
catarrhalis carriage detected by microbiological methods in both
nasopharyngeal and oropharyngeal samples, carriage prevalence
was higher in children (31.4%–38.5%) than in adults (11.7%) [78].
Two of these studies also reported the prevalence of carriage of M.
catarrhalis in an ill population [36,78]. In Yemen, the prevalence
in children with sinusitis was lower than in children with otitis
media or tonsillitis/pharyngitis [78]. However, this study included
only 64 ill children. In Vietnam, the prevalence of M. catarrhalis
carriage in children ,5 years of age with RCP was 28.1%
compared to a prevalence of 42.2% in children with other lower
RTIs (P= 0.001) [36].
Carriage of Staphylococcus aureus
Four studies reported prevalence of S. aureus carriage (Table 4,
Table S6) [43,70,79,80]. All included nasopharyngeal samples. A
longitudinal study in The Gambia found an average prevalence of
nasopharyngeal S. aureus carriage of 20% in healthy infants [43].
The prevalence of carriage was highest in neonates and decreased
with age (from 50% to 10%), in contrast to the prevalence of
carriage of S. pneumoniae, H. influenzae, and M. catarrhalis,
which increased with age during the first year of life [43]. In a
second study in Pakistan, 14.8% of subjects of all ages carried S.
aureus, without a statistically significant difference between age
groups [80]. Similar prevalences of carriage of S. aureus were
reported for two immunocompromised populations, HIV-infected
adults in a low income country (27%) and HIV-infected children
#16 years in a lower-middle income country (26%) [70,79]. The
prevalence of S. aureus carriage in an ill population (with IPD,
AOM, RTI, or sinusitis) has not been reported.
Carriage of Neisseria meningitidis
Nine studies analyzed prevalence of N. meningitidis carriage, all
in healthy populations (Table S7). Four studies used oropharyn-
geal samples, three used nasopharyngeal samples, one used both
oropharyngeal and nasopharyngeal samples, and one used
pharyngeal samples. Carriage rates ranged from 3.17% to 22%
in low income countries [81–86] and from 1.64% to 6.2% in
lower-middle income countries [87–89]. However, most studies
included both children and adults, and only one described the
prevalence of N. meningitidis carriage in young children (0.78% in
children aged 3–24 months in western Democratic Republic of
Congo) [81], the main target age group of this review. In addition,
previous reviews suggest that infants and young children are
unlikely to carry N. meningitidis [25,90]. For these reasons, the
results of the systematic search for this pathogen are not described
further in this review.
Risk factors for carriage
Twenty-five studies evaluated possible risk factors for carriage of
S. pneumoniae. Among healthy subjects, seasonality was identified
as a risk factor for S. pneumoniae carriage in Kenya [51,55],
whereas day care attendance was identified as a risk factor in the
Gaza strip [56]. Conflicting results were reported for several risk
factors, including age, living in crowded conditions or a rural area,
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co-carriage with other pathogens, RTIs, or HIV infection. Co-
carriage with H. influenzae was the only significant risk factor
identified in an immunocompromised population [70], whereas an
age .2 months and no previous antibiotic use were identified as
risk factors for carriage in subjects with IPD, AOM, sinusitis, or
RTI [60,61].
For carriage of H. influenzae, risk factors were an age .2
months, co-colonization with S. pneumoniae, and the winter or
rainy season [55,76]. Risk factors reported for carriage with S.
aureus were living in an urban setting and HIV infection [79,80].
Risk factors for carriage of M. catarrhalis were not reported in any
study.
Association between carriage and disease
An association between carriage and disease was analyzed in
only two studies. One study, conducted in India, linked S.
pneumoniae carriage to RTIs [67]. Children with six or more
episodes of upper RTI had a higher percentage of pneumococcal-
positive swabs than children who had less than three upper RTI
episodes (60% vs. 17.2%; P,0.001). In multivariate analysis,
significant risk factors for upper RTIs in the first year of life were
nasopharyngeal carriage of S. pneumoniae, winter season, and a
lower socioeconomic status of the parents [67]. The other study,
conducted in The Gambia, linked serotype-specific carriage of S.
pneumoniae to IPD [39]. In 43 of 56 (76.8%) children with IPD,
pneumococci isolated from the nasopharynx and from the blood
or other sterile site belonged to the same serotype.
Bacterial density
Only two studies analyzed the density of bacterial carriage
[35,36]. In a group of villages in which only children ,30 months
of age received PCV-7, the density of pneumococcal carriage
(expressed as arbitrary units ranging from 1 to 4) decreased from
2.76 to 1.99 (p= 0.002) in children#5 years and from 2.44 to 1.75
(p = 0.001) in individuals .5 years, suggesting naturally acquired
immunity [35].
The second study reported the density of S. pneumoniae, H.
influenzae, and M. catarrhalis in healthy children, children with
RCP, and children with other lower RTIs [36]. The bacterial load
of S. pneumoniae in the nasopharynx, calculated as genome
equivalent/mL sample secretion, was higher in children with RCP
(7.86106/mL) than in children with other lower RTIs (1.36106/
mL; p,0.0001) and healthy children (7.96105/mL; p,0.0001).
M. catarrhalis bacterial load was higher in children with RCP
(2.56107/mL) and other lower RTIs (3.36107/mL) than in
healthy children (5.56106/mL; p,0.0001). H. influenzae bacte-
rial load was lower in children with other lower RTIs than in
children with RCP (p= 0.003) but there was no significant
difference between healthy children and children with RCP [36].
Impact of vaccination on carriage
Five studies, all in The Gambia, analyzed the impact of
pneumococcal vaccination on S. pneumoniae carriage rate and
serotype distribution (Table S8) [35,42,46,47,53]. All of these
studies were performed before PCV7 was introduced into the
Gambian national childhood immunization program in 2009 [91].
Cheung et al. reported similar total carriage rates for children who
had received the 9-valent PCV (PCV-9; 87.5%) and those who
had received a placebo vaccine (86.2%) [42]. However, compared
to placebo-vaccinated children, PCV-9-vaccinated children were
less likely to carry a VT pneumococcus (22.6% vs. 40.0%; relative
risk = 0.56; 95% CI, 0.49–0.65) and more likely to carry a NVT
pneumococcus (42.7% vs. 26.9%, relative risk = 1.59; 95% CI,
1.41–1.79). Ota et al. analyzed S. pneumoniae carriage rates in 5-,
11-, and 15-month-old children who had received one, two, or
three doses of PCV-7 [47]. Carriage rates were similar overall,
although carriage rates tended to be higher in children who had
received one dose of PCV-7 than in those who had received two or
three doses. At 11 months of age, carriage of a VT pneumococcus
was more common in children who had received one dose of
PCV-7 than in children who had received three doses (20.2% vs.
10.0%, p= 0.005). In a cluster-randomized trial in which children
,30 months of age were vaccinated with PCV-7, Roca et al.
showed that the overall carriage rate in residents decreased from
71% in the pre-PCV-7 vaccination period to 44% following PCV-
7 vaccination [35,53]. Carriage rates increased with age (age
groups: 2–4, 5–14, and $15 years), but they did not differ for any
age group at any time point between the villages in which all
residents received PCV-7 and those in which only children ,30
months of age received PCV-7 [53]. The carriage rates of all age
groups were lower at the first (4–6 months after vaccination) and
second (12 months after vaccination) post-vaccination surveys than
at the pre-vaccination survey. However, by the third post-
vaccination survey, 22 months after vaccination, carriage rates
were higher than at the second survey but still remained below
pre-vaccination rates. Finally, Akinsola et al. compared the
prevalence of S. pneumoniae carriage in children who had
received primary vaccination with PCV-9 followed by a booster
dose of PCV-7 and in age-matched children who received only a
single dose of PCV-7 [46]. They found no significant differences
between the carriage rates or serotype distributions of the two
groups at any time point during a 16–18 month follow-up after
vaccination. In conclusion, all five studies showed that the
prevalence of VT carriage decreased after PCV vaccination,
although the extent of the decrease varied between studies.
Two studies reported the impact of Hib vaccination on H.
influenzae carriage. In one study, Hib carriage was 11% in fully
vaccinated Gambian children who had received the diphtheria-
tetanus-pertussis vaccine alone (control group) compared to only
4.4% for fully vaccinated children who had received diphtheria-
tetanus-pertussis and an Hib conjugate vaccine (p,0.001) [72].
The prevalence of Hib carriage in children who had been partially
vaccinated (either in the control or the vaccinated groups) was
higher than in children who had received full vaccination. In the
second study, conducted in Nepal, none of 27 children ,13 years
of age who had received at least one dose of the Hib vaccine
carried Hib [74].
Discussion
This systematic review of the literature fills an important gap in
knowledge on the carriage of five key pathogens in low and lower-
middle income countries. The review found that nasopharyngeal
carriage was frequent in these countries. The prevalences of
carriage for S. pneumoniae, H. influenzae, and M. catarrhalis
were generally higher in low income countries than in lower-
middle income countries and were generally higher in children
than in adults. The prevalence of S. aureus carriage was highest in
neonates.
In low and lower-middle income countries, the prevalence of
pneumococcal carriage was high in young children (up to 93.4%
in children 2–4 years of age). Furthermore, carriage was acquired
within the first months of life and persisted in older children and
adults, although at lower levels [50,51,53,54]. In contrast, in
upper-middle and high income countries, the highest prevalence of
pneumococcal nasopharyngeal carriage recorded was 58% (in
healthy children ,3 years of age) [92]. This difference could be
due to the frequent overcrowded living conditions in developing
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countries. This view is supported by the high prevalence of
carriage found among children living in orphanages or attending
day-care centers in industrialized countries and among indigenous
populations [93–96]. Malnutrition, more common in the devel-
oping countries, could also favor carriage and disease, as
previously suggested [97].
In addition to a high prevalence of S. pneumoniae carriage,
young children also have a higher pneumococcal density in the
nasopharynx than older individuals [35]. This may partly explain
why children are more efficient than adults at transmitting S.
pneumoniae. The lower density in adults may be due to the
progressive acquisition of immunity, less frequent close contact
between individuals, better hygiene, or a combination of these
factors. IPD is probably also a substantial public health problem
for adults in many developing countries [98], particularly for
countries with a high incidence of HIV [99–101], but this has not
been well documented. As life expectancy increases in these
countries, the proportion of the adult population with risk factors
for IPD, such as diabetes, cardiovascular diseases, and chronic
RTIs, is increasing [102]. It is hoped that an indirect effect of
pediatric pneumococcal vaccination, through reduced carriage of
VT pneumococci, will also be seen in these at risk populations, as
it has occurred in the US and Europe [5,8,13] but this will occur
only if the major route of pneumococcal transmission in these
countries is from young children to adults. There is currently little
information to support this expectation but longitudinal studies in
Kenya and rural Gambia have suggested that intra-household
transmission is more important than community transmission and
that young children commonly introduce S. pneumoniae into the
household, with subsequent spread to other children and adults
[51,54]. Vaccinations strategies against pneumococcal disease
need to target young children, but a strong case can be made for
catch-up campaigns in older children in developing countries
because children up to nine years of age can effectively transmit S.
pneumoniae [51].
The review has shown that residents of low and lower-middle
income countries carry a wide variety of pneumococcal serotypes.
Identifying clear trends in the serotype distributions was challeng-
ing due to the disparate geographic regions represented and to
large variations in the types of studies reviewed and sets of
serotypes analyzed in each study. Despite this, the five most
common serotypes reported (6A, 6B, 14, 19F, and 23F) are among
the seven serotypes that globally cause most IPD in children
worldwide [103]. The two other serotypes, 1 and 5, are rarely
isolated in carriage studies, although they have been found in
epidemics of invasive pneumococcal disease [3,104,105]. All these
serotypes are included in the two second generation PCVs –
PHiD-CV and PCV-13.
Studies in industrialized countries have established a temporal
association between pneumococcal carriage and disease, especially
for AOM. We found only limited data on associations between
disease and carriage in low and lower-middle income countries,
although associations between S. pneumoniae and both IPD and
RTIs have been described [39,67].
Few carriage studies have analyzed more than one pathogen
and the interactions between them. In The Gambia, approxi-
mately 90% of infants co-carried S. pneumoniae with at least one
other pathogen, most often H. influenzae or M. catarrhalis [43].
Co-infections with multiple pathogens can subvert mucosal
immune responses to carriage in the upper respiratory tract and
can alter disease outcome [106]. In contrast, an inverse association
has been found between S. pneumoniae and S. aureus
[21,28,29,106]. However, most studies do not consider that risk
factors for these infections may be different and that bacterial
interactions within the nasopharynx may influence the prevalence
of carriage with individual bacteria.
Only five studies included PCV-vaccinated populations and two
studies included Hib-vaccinated populations. Results were con-
flicting for the impact of PCV vaccination on the overall
pneumococcal carriage, although all studies showed that the
prevalence of VT carriage decreased after PCV vaccination and
that the prevalence of Hib carriage decreased after Hib
vaccination. A long-term follow-up of the village-randomized
study of PCV-7 in The Gambia found that the decrease in VT
carriage was sustained four years after vaccination and that
carriage of NVT pneumococci did not significantly increase [107].
Also, PCV-7 indirectly reduced carriage of VT pneumococci in
unvaccinated infants ,8 weeks of age [108]. More data will be
available on the long-term impact of PCV immunization as the use
of these vaccines continues to increase in lower income countries.
The results of this review need to be interpreted in light of
several considerations. S. pneumoniae was the only pathogen for
which prevalence of carriage was available for all three subpop-
ulations (healthy, immunocompromised, and ill). Heterogeneity
between studies may also have hampered direct comparisons. For
instance, differences were noted in study design, the definition of
prevalence, sampling technique, laboratory methods, the type of
sample, and the period between sample collection and vaccination.
Notably, not all the studies of S. pneumoniae followed the WHO
recommendations for measuring nasopharyngeal carriage [44,45].
Nasopharyngeal and oropharyngeal swabs were used in the
studies, both of which differ in sensitivity for detecting respiratory
pathogens [109,110]. Also, some standard methods for bacterial
identification do not reliably distinguish H. influenzae from H.
haemolyticus, a respiratory tract commensal [111]. In addition,
variation between studies may be due in part to the type of settings
where a study was done. Indeed, several studies included children
from outpatient clinics, and selection bias is usually higher in these
settings than in studies including children from the community.
Studies in the low income countries were highly heterogeneous
(I2 = 98%), so that the pooled estimate for pneumococcal carriage
should be interpreted with caution, as it reflects only findings from
countries where carriage studies have been published. In contrast,
heterogeneity was low between studies from the lower-middle
income countries (I2 = 0%). We were unable to perform a meta-
analysis for H. influenzae, S. aureus, and M. catarrhalis because
of the few studies available. Most studies included in this review
had a cross-sectional design, which prevents assessing the effect of
season on prevalence of carriage. Finally, because seasonality is a
risk factor for carriage for S. pneumoniae and the other pathogens
[51,55,76], it might be a confounding factor in comparisons of
carriage rates between different studies.
None of the studies included in the review were from Central
or South America, the Caribbean, or Europe due to the absence
of any publications that met the inclusion criteria. In addition, we
did not include upper-middle income countries in the analysis
even though some populations within these countries may share
characteristics with populations in low or lower-middle income
countries. For instance, in one study in South Africa, prevalence
of pneumococcal carriage was high (22.5%–61.0%) in children
younger than five years of age [112], whereas a study in Costa
Rica showed that infants acquire nasopharyngeal carriage of S.
pneumoniae at a rate (3.1% at one month of age and 19.4% at
one year of age) comparable to that seen in developed countries
[113].
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Conclusions
With support from the GAVI Alliance, PCVs of higher
valencies are being rapidly introduced into the Expanded
Programme on Immunization of low and lower-middle income
countries [2,31]. In the large number of countries where large-
scale PCV vaccination is being introduced careful surveillance
of IPD is needed. However, due to limited resources, popula-
tion-based IPD surveillance systems similar to those in the
industrialized countries will probably not be possible in most
low and lower-middle income countries. Because carriage
surveys are relatively cheap and possible compared to popula-
tion-based IPD surveillance, carriage data could be used instead
to indirectly monitor vaccine herd effects and serotype
replacement after the introduction of PCVs [114] and in the
process for future vaccine licensure [115]. However, the
relevance of carriage studies for serotype replacement still
needs to be properly assessed, because in many countries,
although replacement in carriage is complete, the replacement
in disease is small [7,8,14,16,17]. Because the dynamics of
carriage within populations are complex, carefully designed
multi-year, longitudinal carriage studies will be needed.
Our systematic review found high prevalences of bacterial
carriage in children from low and lower-middle income countries.
Although data were limited, we expect that the introduction of
routine immunization programs against S. pneumoniae, H.
influenzae, and N. meningitidis will help reduce the burden of
infectious diseases in these countries and that studies of the effects
on carriage may provide important data that can be used to
understand overall vaccine effectiveness.
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